Who Attends?

The therapeutic potential of the human microbiome shows great promise, but in order for this potential to be realized, lessons and key insights from organizations who are directly involved in developing microbiome-based therapeutics & biomarkers must be shared and disseminated. The Microbiome Movement – Drug Development Summit’s exclusive focus on overcoming the challenges of therapeutic & biomarker development means it’s an unparalleled opportunity for you to engage in meaningful discussion with 250+ pharmaceutical, biotech and translational researchers at the forefront of this growing field.

200+ Organizations Joined Us In 2018, Including

MDD All

“A great opportunity to meet some of the brightest minds and leading entrepreneurs in the industry. A key event for anyone intending to translate microbiome science into impactful products for patients.”

Chr. Hansen

The Microbiome Movement has proven to deliver a superior conference where scientific content is consistently emphasized concurrently with  relationship building opportunities. An excellent platform for advancement of the microbiome industry."

CosmosID

Audience Breakdown

Company Type:

4295_Microbiome_Drug_Development_CompanyType

Seniority:

4295_Microbiome_Drug_Development_Seniority